Literature DB >> 11979132

Bronchiectasis.

J Angrill1, C Agustí, A Torres.   

Abstract

Bronchiectasis is a structural derangement of the bronchial wall that is characterized by airway dilatation and bronchial wall thickening. As a result of this abnormality, chronic inflammation and secondary microbial infections occur, which cause additional damage to the bronchi. Recent insights into the potential pathophysiological mechanisms of bronchiectasis, as well as improvements in computed tomography and the development of new pharmacological agents, might help to improve the clinical management of this chronic infective/inflammatory disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11979132     DOI: 10.1097/00001432-200104000-00014

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  3 in total

1.  Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients.

Authors:  Matthew C Wolfgang; Jeevan Jyot; Andrew L Goodman; Reuben Ramphal; Stephen Lory
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

2.  The immune response and its therapeutic modulation in bronchiectasis.

Authors:  Massoud Daheshia; James D Prahl; Jacob J Carmichael; John S Parrish; Gilbert Seda
Journal:  Pulm Med       Date:  2012-10-10

3.  Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.

Authors:  L Máiz; R Girón; C Olveira; M Vendrell; R Nieto; M A Martínez-García
Journal:  BMC Infect Dis       Date:  2016-08-22       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.